Form 15-12G UNIVERSAL BIOSENSORS
|
|
|
| ||
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________
FORM 15
__________________
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 000-52607
__________________
UNIVERSAL BIOSENSORS, INC.
(Exact name of registrant as specified in its charter)
__________________
1 Corporate Avenue
Rowville, 3178, Victoria
Australia
+61 3 9213 9000
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Common Stock, $.0001 par value per share
(Title of each class of securities covered by this Form)
None.
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
__________________
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1) | X |
Rule 12g-4(a)(2) | ☐ |
Rule 12h-3(b)(1)(i) | X |
Rule 12h-3(b)(1)(ii) | ☐ |
Rule 15d-6 | ☐ |
Rule 15d-22(b) | ☐ |
Approximate number of holders of record as of the certification or notice date: One
|
|
|
| ||
Pursuant to the requirements of the Securities Exchange Act of 1934, Universal Biosensors, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||
|
|
|
|
| ||||||||||
Date: November 14, 2025 |
|
| By: | /s/ Peter Mullin | ||||||||||
|
|
| Name: | Peter Mullin | ||||||||||
|
|
| Title: | Chief Executive Officer | ||||||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Agronomics Limited Announces Net Asset Value as at 30 June 2026
- BMGL Regains Compliance With Nasdaq Minimum Bid Price Requirement
- Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share